These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9037068)

  • 1. Recovery of pituitary function after treatment with a targeted cytotoxic analog of luteinizing hormone-releasing hormone.
    Kovacs M; Schally AV; Nagy A; Koppan M; Groot K
    Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1420-5. PubMed ID: 9037068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted cytotoxic analogue of luteinizing hormone-releasing hormone (LH-RH) only transiently decreases the gene expression of pituitary receptors for LH-RH.
    Kovacs M; Schally AV; Csernus B; Busto R; Rekasi Z; Nagy A
    J Neuroendocrinol; 2002 Jan; 14(1):5-13. PubMed ID: 11903807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of a targeted cytotoxic analog of luteinizing hormone-releasing hormone inhibits growth of estrogen-independent MDA-MB-231 human breast cancers in nude mice.
    Kahán Z; Nagy A; Schally AV; Halmos G; Arencibia JM; Groot K
    Breast Cancer Res Treat; 2000 Feb; 59(3):255-62. PubMed ID: 10832595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 inhibits the growth of PC-82 human prostate cancer in nude mice.
    Koppán M; Nagy A; Schally AV; Plonowski A; Halmos G; Arencibia JM; Groot K
    Prostate; 1999 Feb; 38(2):151-8. PubMed ID: 9973101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic analogs of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500-1000 times more potent.
    Nagy A; Schally AV; Armatis P; Szepeshazi K; Halmos G; Kovacs M; Zarandi M; Groot K; Miyazaki M; Jungwirth A; Horvath J
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7269-73. PubMed ID: 8692981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of luteinizing hormone-releasing hormone analogs containing cytotoxic radicals on the function of rat pituitary cells: tests in a long term superfusion system.
    Rékási Z; Szöke B; Nagy A; Groot K; Rékási ES; Schally AV
    Endocrinology; 1993 May; 132(5):1991-2000. PubMed ID: 8477650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective induction of apoptosis by the cytotoxic analog AN-207 in cells expressing recombinant receptor for luteinizing hormone-releasing hormone.
    Danila DC; Schally AV; Nagy A; Alexander JM
    Proc Natl Acad Sci U S A; 1999 Jan; 96(2):669-73. PubMed ID: 9892691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete regression of MX-1 human breast carcinoma xenografts after targeted chemotherapy with a cytotoxic analog of luteinizing hormone-releasing hormone, AN-207.
    Kahán Z; Nagy A; Schally AV; Halmos G; Arencibia JM; Groot K
    Cancer; 1999 Jun; 85(12):2608-15. PubMed ID: 10375109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted cytotoxic luteinizing hormone releasing hormone (LH-RH) anlalogs inhibit growth of estrogen independent MXT mouse mammary cancers in vivo by decreasing cell proliferation and inducing apoptosis.
    Szepeshazi K; Schally AV; Nagy A; Halmos G; Groot K
    Anticancer Drugs; 1997 Nov; 8(10):974-87. PubMed ID: 9436641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of suckling and of suckling followed by TRH or LH-RH on plasma prolactin, TSH, GH and FSH.
    Jeppsson S; Nilsson KO; Rannevik G; Wide L
    Acta Endocrinol (Copenh); 1976 Jun; 82(2):246-53. PubMed ID: 818858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary hormone responses to hypothalamic releasing hormones in acromegaly.
    Cantalamessa L; Reschini E; Catania A; Giustina G
    Acta Endocrinol (Copenh); 1976 Dec; 83(4):673-83. PubMed ID: 826061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective treatment of metastatic MDA-MB-435 human estrogen-independent breast carcinomas with a targeted cytotoxic analogue of luteinizing hormone-releasing hormone AN-207.
    Chatzistamou L; Schally AV; Nagy A; Armatis P; Szepeshazi K; Halmos G
    Clin Cancer Res; 2000 Oct; 6(10):4158-65. PubMed ID: 11051271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a cytotoxic analog of LH-RH (T-98) on the growth of estrogen-dependent MXT mouse mammary cancers: correlations between growth characteristics and EGF receptor content of tumors.
    Szepeshazi K; Schally AV; Halmos G; Szoke B; Groot K; Nagy A
    Breast Cancer Res Treat; 1996; 40(2):129-39. PubMed ID: 8879679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth inhibition of human ovarian cancers by cytotoxic analogues of luteinizing hormone-releasing hormone.
    Miyazaki M; Nagy A; Schally AV; Lamharzi N; Halmos G; Szepeshazi K; Groot K; Armatis P
    J Natl Cancer Inst; 1997 Dec; 89(23):1803-9. PubMed ID: 9392622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LH-RH analogue carrying a cytotoxic radical is internalized by rat pituitary cells in vitro.
    Szöke B; Horváth J; Halmos G; Rékási Z; Groot K; Nagy A; Schally AV
    Peptides; 1994; 15(2):359-66. PubMed ID: 8008640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of proliferation of small intestinal and bronchopulmonary neuroendocrine cell lines by using peptide analogs targeting receptors.
    Kidd M; Schally AV; Pfragner R; Malfertheiner MV; Modlin IM
    Cancer; 2008 Mar; 112(6):1404-14. PubMed ID: 18224665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine effects on in vitro responsiveness of anterior pituitary hormone release to dopamine and thyrotropin-releasing hormone in young female rats.
    Moreno ML; Villanúa MA; Arce A; Esquifino AI
    J Neuroendocrinol; 1995 Oct; 7(10):765-74. PubMed ID: 8563719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone response to thyrotropin-releasing hormone in liver cirrhosis: unique alteration in anterior pituitary responsiveness to hypothalamic hormones.
    Salerno F; Cocchi D; Lampertico M; Manneschi M; Monza G; Müller EE
    Horm Metab Res; 1982 Sep; 14(9):482-6. PubMed ID: 6128295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regression of rat Dunning R-3327-H prostate carcinoma by treatment with targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 containing 2-pyrrolinodoxorubicin.
    Jungwirth A; Schally A; Nagy A; Pinski J; Groot K; Galvan G; Szepeshazi K; Halmos G
    Int J Oncol; 1997 May; 10(5):877-84. PubMed ID: 21533457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of starvation in rats on serum levels of follicle stimulating hormone, luteinizing hormone, thyrotropin, growth hormone and prolactin; response to LH-releasing hormone and thyrotropin-releasing hormone.
    Campbell GA; Kurcz M; Marshall S; Meites J
    Endocrinology; 1977 Feb; 100(2):580-7. PubMed ID: 401735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.